The third webinar in Us TOO's series, What is Right for Me in My Prostate Cancer Treatment?, is a discussion on the topic of Biomarkers. Biomarkers are measurements that give information about the activity of cancer and potential response to therapy. These can be measured in blood, but also include imaging findings. The use of biomarkers may help men personalize therapy more effectively and may contribute to understanding response to treatment. 

Thursday, May 20
7:00 - 8:30pm Central

Register at:
Meet the Moderator
Alicia Morgans, MD, MPH is an Associate Professor of Medicine in the Division of Hematology/Oncology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois. She specializes in investigating complications of systemic therapy for prostate cancer survivors, including the study of skeletal, cardiovascular, diabetic, and cognitive complications of prostate cancer survivorship. She also studies the way patients and their care teams make treatment decisions for metastatic prostate cancer. She has been awarded several Prostate Cancer Foundation grants to investigate the cognitive effects and quality of life effects of hormonal treatments in advanced prostate cancer, and she serves as the Principal Investigator for multiple therapeutic prostate cancer and bladder cancer clinical trials at Northwestern.
Dr. Daniel Spratt - the Vincent Smith Professor and Chairman of the Department of Radiation Oncology at UH Cleveland Medical Center/Case Western Reserve University School of Medicine

Moderated by:
Dr. Alicia Morgans - Associate Professor of Medicine, Northwestern University Feinberg School of Medicine

Other Upcoming Webinars in this Series:
Imaging - Thursday, June 24
with Dr. Laurence Klotz and Dr. Brian Helfand

Genetics and Genomics - Thursday, July 29
with Dr. Heather H. Cheng and Dr. Brittany Szymaniak

For Sponsorship Opportunities, Please Email James Hutson, Us TOO Director of Development at: or call 630-795-1002.
Presented by:

Series Sponsored by: